8-K ·Filed Apr 27, 2026

XNCR

Xencor Inc
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001326732-26-000030
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No trading signal from this routine governance filing. Monitor for any future executive departures or change-in-control events that could trigger severance payments.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
XNCR ▲ +60.74% at T+60d
NEUTRAL call ✓ call won +60.74% · α vs SPY +56.75% · entry $12.15 → $19.53
Entry anchored
Apr 27, 03:59 PM ET
via exchange tick
T+1d
-4.20%
call -4.20% · α -4.19%
$11.64
settled 5mo ago
T+5d
+9.96%
call +9.96% · α +8.27%
$13.36
settled 5mo ago
T+20d
-4.28%
call -4.28% · α -9.75%
$11.63
settled 4mo ago
T+60d
+60.74%
call +60.74% · α +56.75%
$19.53
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Xencor adopted an Executive Severance Policy covering VPs and above (excluding CEO), providing lump-sum base salary (15 months for EVPs/NEOs), COBRA premiums, and double-trigger change-in-control benefits. This is a routine compensatory arrangement with no immediate financial impact or executive changes.

Key Facts

  • Severance policy adopted on April 23, 2026, covering Vice Presidents and above (excluding CEO)
  • Standard termination provides lump sum of 15 months base salary for EVPs/NEOs plus COBRA premiums
  • Change-in-control termination adds 15 months target bonus, prorated annual bonus, and full equity acceleration
  • No executive departures, appointments, or financial data disclosed

Financial Impact

No immediate financial impact; potential future severance obligations not quantified

Risk Factors

  • Potential future severance costs if executives are terminated without cause or resign for good reason

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001326732-26-000030
Document: xncr-20260423.htm0001326732-26-000030
Document: 0001326732-26-000030-index-headers.html0001326732-26-000030
Document: 0001326732-26-000030-index.html0001326732-26-000030
Document: 0001326732-26-000030.txt0001326732-26-000030
10 reports for XNCR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +67.24%May 5, 2026
Filters
Rows
Reports for XNCR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$20.00 $26.62▲ +33.10%▲ +32.50%$24.84 (+24.20%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$12.64 $14.95▲ +18.28%▲ +17.74%$24.84 (+96.52%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$12.21 $14.96▲ +22.52%▲ +23.27%$24.84 (+103.44%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$12.21 $14.96▲ +22.52%▲ +23.27%$24.84 (+103.44%)
May 6, 2026
21w ago
8-K
BEARISH ★ 7/10
$12.31 $11.42▲ +7.23%▲ +10.37%$24.84 (−101.79%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$12.85 $11.21▼ −12.76%▼ −17.72%$24.84 (+93.31%)
Apr 27, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$12.15 $11.63▼ −4.28%▼ −9.75%$24.84 (+104.44%)
Mar 5, 2026
30w ago
Insider Cluster
NEUTRAL ★ 3/10
$11.16 $12.81▲ +14.78%▲ +18.57%$24.84 (+122.58%)
Mar 4, 2026
30w ago
8-K
BEARISH ★ 8/10
$11.16 $12.81▼ −14.78%▼ −18.57%$24.84 (−122.58%)
Feb 25, 2026
31w ago
8-K
BULLISH ★ 7/10
$11.98 $12.40▲ +3.51%▲ +8.74%$24.84 (+107.35%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access